AKT1 and diabetic kidney disease: The Jiedu Tongluo Baoshen Formula similarly inhibits the PI3K/Akt/mTOR signaling pathway, enhancing podocyte autophagy and reducing podocyte injury, thus offering an effective treatment for DKD (Jin et al., 2022).